Optimal Dosing of the Poly(ADP-Ribose) Polymerase Inhibitor Niraparib

Laurie Cohen, MD, on when and how to retest for GH deficiency, how soon to start GH replacement in cancer survivors from Clinical Care Options (CCO)

Laurie E. Cohen, MD Released: April 22, 2021

Danielle Friedman, MD, on adipose dysfunction, insulinopenia, obesity, and diabetes after irradiation in cancer survivors

Danielle N. Friedman, MD, MS Released: April 22, 2021

Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2021, from Clinical Care Options (CCO)

Jubilee Brown, MD Ursula Matulonis, MD Released: April 8, 2021

Podcast episode with expert insights on new data from SGO 2021 in endometrial and ovarian cancers, from Clinical Care Options (CCO)

Jubilee Brown, MD Ursula Matulonis, MD Released: April 7, 2021